Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Thrice-weekly insulin injection with nurse's support for diabetic hemodialysis patients having difficulty with self injection.

Shoji T, Emoto M, Mori K, Morioka T, Fukumoto S, Takahashi T, Matsumoto A, Nishizawa Y, Inaba M.

Osaka City Med J. 2012 Jun;58(1):35-8.

PMID:
23094512
[PubMed - indexed for MEDLINE]
2.
3.

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.

Yki-Järvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Ryysy L, Salo S, Seppälä P, et al.

N Engl J Med. 1992 Nov 12;327(20):1426-33.

PMID:
1406860
[PubMed - indexed for MEDLINE]
Free Article
4.

Comparison of different insulin regimens in elderly patients with NIDDM.

Wolffenbuttel BH, Sels JP, Rondas-Colbers GJ, Menheere PP, Nieuwenhuijzen Kruseman AC.

Diabetes Care. 1996 Dec;19(12):1326-32.

PMID:
8941458
[PubMed - indexed for MEDLINE]
5.

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial.

Fritsche A, Schweitzer MA, Häring HU; 4001 Study Group.

Ann Intern Med. 2003 Jun 17;138(12):952-9.

PMID:
12809451
[PubMed - indexed for MEDLINE]
6.

Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis.

Mirani M, Berra C, Finazzi S, Calvetta A, Radaelli MG, Favareto F, Graziani G, Badalamenti S.

Diabetes Technol Ther. 2010 Oct;12(10):749-53. doi: 10.1089/dia.2010.0052.

PMID:
20809678
[PubMed - indexed for MEDLINE]
7.

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.

PMID:
18936501
[PubMed - indexed for MEDLINE]
8.

Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.

Ligthelm RJ, Mouritzen U, Lynggaard H, Landin-Olsson M, Fox C, le Devehat C, Romero E, Liebl A.

Exp Clin Endocrinol Diabetes. 2006 Oct;114(9):511-9.

PMID:
17115349
[PubMed - indexed for MEDLINE]
9.

Efficacy of pioglitazone on type 2 diabetic patients with hemodialysis.

Abe M, Kikuchi F, Okada K, Kaizu K, Matsumoto K.

Diabetes Res Clin Pract. 2008 Jun;80(3):432-8. doi: 10.1016/j.diabres.2008.01.028. Epub 2008 Mar 17.

PMID:
18346811
[PubMed - indexed for MEDLINE]
10.

Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.

Kazda C, Hülstrunk H, Helsberg K, Langer F, Forst T, Hanefeld M.

J Diabetes Complications. 2006 May-Jun;20(3):145-52.

PMID:
16632233
[PubMed - indexed for MEDLINE]
11.

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.

Bretzel RG, Nuber U, Landgraf W, Owens DR, Bradley C, Linn T.

Lancet. 2008 Mar 29;371(9618):1073-84. doi: 10.1016/S0140-6736(08)60485-7. Erratum in: Lancet. 2008 Aug 30;372(9640):718.

PMID:
18374840
[PubMed - indexed for MEDLINE]
12.

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK.

Diabetes Care. 1998 Apr;21(4):574-9.

PMID:
9571345
[PubMed - indexed for MEDLINE]
13.

Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes.

Sargin H, Sargin M, Altuntaş Y, Sengül AM, Orbay E, Seber S, Uçak S, Yayla A.

Diabetes Res Clin Pract. 2003 Nov;62(2):79-86.

PMID:
14581144
[PubMed - indexed for MEDLINE]
14.

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

Garber AJ, Wahlen J, Wahl T, Bressler P, Braceras R, Allen E, Jain R.

Diabetes Obes Metab. 2006 Jan;8(1):58-66.

PMID:
16367883
[PubMed - indexed for MEDLINE]
15.

A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.

Jacober SJ, Scism-Bacon JL, Zagar AJ.

Diabetes Obes Metab. 2006 Jul;8(4):448-55.

PMID:
16776752
[PubMed - indexed for MEDLINE]
17.

Comparison of safety and efficacy of insulin glargine and neutral protamine hagedorn insulin in older adults with type 2 diabetes mellitus: results from a pooled analysis.

Lee P, Chang A, Blaum C, Vlajnic A, Gao L, Halter J.

J Am Geriatr Soc. 2012 Jan;60(1):51-9. doi: 10.1111/j.1532-5415.2011.03773.x.

PMID:
22239291
[PubMed - indexed for MEDLINE]
18.

[Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen].

Bu S, Guo XH, Yang WY, Lu GZ, Yang ZJ, Ren TT, Gao Y.

Zhonghua Yi Xue Za Zhi. 2007 Nov 27;87(44):3115-8. Chinese.

PMID:
18269868
[PubMed - indexed for MEDLINE]
19.

Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.

Biesenbach G, Bodlaj G, Ebner S, Biesenbach P, Pieringer H.

Int Urol Nephrol. 2011 Dec;43(4):1155-60. doi: 10.1007/s11255-010-9804-x. Epub 2010 Jul 20.

PMID:
20640938
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk